Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2000
12/05/2000US6156535 Nucleotide sequences coding inhibitor of apoptosis protein; for diagnosing a cell proliferation defect
12/05/2000US6156523 Serine/threonine protein kinases
12/05/2000US6156518 Methods of using DNA encoding human alpha 1 adrenergic receptors
12/05/2000CA2195974C 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines
12/04/2000WO2000075103A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) $g(a)
12/01/2000CA2310272A1 Transdermal estrogen agonist-antagonist therapy
11/2000
11/30/2000WO2000072023A2 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000WO2000072015A2 Diagnostics and therapeutics for cardiovascular disorders
11/30/2000WO2000071753A2 Diagnostics and therapeutics for restenosis
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071716A2 Vascular endothelial growth factor dimers
11/30/2000WO2000071713A1 Vascular endothelial growth factor variants
11/30/2000WO2000071708A2 Use of ef-ts for treating smooth muscle cell hyperplasia
11/30/2000WO2000071585A1 Human antibodies to staphylococcus aureus
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071560A1 Methods of modulating activity of prokaryotic ribosomes
11/30/2000WO2000071558A1 Orally active a1 adenosine receptor agonists
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071540A1 Hydrochloride of fused-heterocycle compound
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071516A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071515A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071513A1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071507A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071502A1 Hydrazide derivatives
11/30/2000WO2000071493A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071118A1 Phospholipase a2-specific inhibiting compounds
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000071102A2 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000043028A3 Method of treating chronic cardiac disease
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000041687A3 Composition and methods for administration of water-insoluble paclitaxel derivatives
11/30/2000WO2000040241A3 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000DE19924819A1 Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) Substituted Phenylcyclohexancarbonsäurebenzylamid (adenosine uptake inhibitors)
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374820A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374788A1 Inhibitors of factor xa
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2374646A1 Inhibitors of factor xa
11/30/2000CA2374641A1 Inhibitors of factor xa
11/30/2000CA2374531A1 Diagnostics and therapeutics for restenosis
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374050A1 Vascular endothelial growth factor dimers
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373285A1 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000CA2373221A1 Human antibodies to staphylococcus aureus
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371904A1 Inhibitors of factor xa
11/30/2000CA2369746A1 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
11/29/2000EP1054963A1 Sequences of an ih ionic channel and the use thereof
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054876A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054670A2 Use of chelating agents in the treatment of atherosclerotic conditions
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054633A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
11/29/2000EP1054594A1 Inotropic and diuretic effects of exendin and glp-1
11/29/2000EP0862453A4 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0655055B1 Tachykinin antagonists
1 ... 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 ... 1595